Literature DB >> 15470221

Prevention of hepatocellular carcinoma.

Jack R Wands.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15470221     DOI： 10.1056/NEJMe048237

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  24 in total

Review 1.  Hepatocellular carcinoma: therapy and prevention.

Authors:  Hubert E Blum
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

2.  A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly.

Authors:  Stephen J Stray; Christina R Bourne; Sreenivas Punna; Warren G Lewis; M G Finn; Adam Zlotnick
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

3.  Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery.

Authors:  Kazuhiro Kondo; Kazuo Chijiiwa; Mayumi Funagayama; Masahiro Kai; Kazuhiro Otani; Jiro Ohuchida
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

4.  American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.

Authors:  Robin T Zon; Elizabeth Goss; Victor G Vogel; Rowan T Chlebowski; Ismail Jatoi; Mark E Robson; Dana S Wollins; Judy E Garber; Powel Brown; Barnett S Kramer
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

Review 5.  Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors.

Authors:  Yasir Waheed; Talha Shafi; Sher Zaman Safi; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

6.  Genetic predictors of the response to the treatment of hepatitis C virus infection.

Authors:  Pavlina Dzekova-Vidimliski; Igor G Nikolov; Nadica Matevska-Geshkovska; Yana Boyanova; Nina Nikolova; Grigore Romanciuc; Dan Dumitrascu; Viktorija Caloska-Ivanova; Nenad Joksimovic; Krasimir Antonov; Lyudmila Mateva; Lionel Rostaing; Aleksandar Dimovski; Aleksandar Sikole
Journal:  Bosn J Basic Med Sci       Date:  2015-11-12       Impact factor: 3.363

7.  Interactions of ketoamide inhibitors on HCV NS3/4A protease target: molecular docking studies.

Authors:  Abdul Wadood; Muhammad Riaz; Syed Babar Jamal; Masaud Shah
Journal:  Mol Biol Rep       Date:  2014-01       Impact factor: 2.316

8.  High seroprevalence of human herpesvirus type 8 in patients with hepatocellular carcinoma.

Authors:  C-C Su; K-C Tseng; M-N Lin; T-C Hsieh; T-Y Chu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-20       Impact factor: 3.267

9.  Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication.

Authors:  Ying-Chun Wang; Xu Yang; Lan-Hua Xing; Wei-Zong Kong
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

10.  Inhibition of hepatitis B virus replication by small interference RNA induces expression of MICA in HepG2.2.15 cells.

Authors:  Kai-Fu Tang; Min Chen; Jing Xie; Guan-Bin Song; Yi-Song Shi; Qi Liu; Zhe-Chuan Mei; Alexander Steinle; Hong Ren
Journal:  Med Microbiol Immunol       Date:  2008-08-07       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.